home / stock / cmps / cmps articles

CMPS Articles, COMPASS Pathways Plc - From 11/24/23

Stock Information
Company Name: COMPASS Pathways Plc
Stock Symbol: CMPS
Market: NASDAQ
Website: compasspathways.com
Menu
CMPS CMPS Quote CMPS Short CMPS News CMPS Articles CMPS Message Board
Get CMPS Alerts

News, Short Squeeze, Breakout and More Instantly...
Compass Pathways to participate in upcoming Evercore investor conference | Benzinga

LONDON, Nov. 24, 2023 (GLOBE NEWSWIRE) -- Compass Pathways plc (NASDAQ:CMPS), a biotechnology company dedicated to accelerating patient access t...
UK Psychedelics: Phase 3 Depression & Alcohol Addiction Trials, New London Center | Benzinga

The U.K. Medicines and Healthcare Regulatory Agency (MHRA) has green-lighted two separate Phase 3 trials conducted by Compass Pathways (NASDAQ: CMP...

Atai Life Sciences' Q3 Earnings: Near $20M Burned QoQ, Says Funding 'Sufficient' To Streamline 2026 | Benzinga

Clinical-stage psychedelics company atai Life Sciences (NASDAQ: ATAI) reported its financial results and corporate updates for the third quart...

Azenta Reports Upbeat Earnings, Joins Talis Biomedical, Sally Beauty And Other Big Stocks Moving Higher On Tuesday | Benzinga

U.S. stocks traded higher, with the Dow Jones gaining around 500 points on Tuesday. Shares of Azenta, Inc. (NASDAQ: AZTA) rose on Tuesday after the...
Psyched: Veterans & Psychedelics, $100M IPO, Cybin's $64M Offering, Worldwide Events & More | Benzinga

Veterans Day: Can Psychedelic Treatment Help Stem PTSD-Related Suicides Among Veterans? An average of 17 veterans committed suicide per day in 2020...

Psyched: DEA's Denial Overruled, Fed Psychedelics Change, Psilocybin For Depression, States Reform & More | Benzinga

DEA Psilocybin Rescheduling Denial Overruled By Federal Appeals Court The U.S. Court of Appeals for the Ninth Circuit ruled against the Drug Enforc...

COMPASS Pathways Q3 2023 Results: Cash Injection To Sustain Phase 3 Psilocybin Program | Benzinga

COMPASS Pathways plc (NASDAQ: CMPS), the London-headquartered psychedelics biotech company reported financial results for the third quarter 20...
Psyched: Cybin's Center Stage In Novel Psychedelics, Musk & Ramaswamy, Britney's Memoirs And More | Benzinga

Cybin Officially Owns Small Pharma, Gets Three New International Patents Granted Psychedelics companies Cybin Inc. (NYSE: CYBN) and Small Pharma In...

COMPASS Pathways announces CFO transition | Benzinga

LONDON, Oct. 26, 2023 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (NASDAQ:CMPS) ("COMPASS" or the "company"), a biotechnology company dedicated to ...

COMPASS Pathways plc to Announce Third Quarter 2023 Financial Results on November 2, 2023 | Benzinga

LONDON, Oct. 24, 2023 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (NASDAQ:CMPS), a biotechnology company dedicated to accelerating patient access t...
Previous 10 Next 10